Regulation of sarco(endo)plasmic reticulum Ca2+-ATPase and calsequestrin gene expression in the heart

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 8, 2012, Pages 1017-1028

  Zarain Herzberg, Angel ^a   Estrada Avilés, Rafael ^a   Fragoso Medina, Jorge ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Calsequestrin; Gene expression; Heart; Sarcoplasmic reticulum; SERCA2; Transcription

Indexed keywords

ANGIOTENSIN II; CALCIUM; CALCIUM CHANNEL; CALSEQUESTRIN; CALSEQUESTRIN 2; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE P38; NORADRENALIN; PARATHYROID HORMONE; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C; PROTEIN SERCA2; PROTEIN SERCA2A; PROTEIN SERCA2B; PROTEIN SERCA2C; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE 1; THYROID HORMONE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CASQ2 GENE; CYTOSOL; DOWN REGULATION; ENZYME REGULATION; GENE; GENE EXPRESSION REGULATION; HEART BEAT; HEART CONTRACTION; HEART CYCLE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SARCOPLASMIC RETICULUM; SERCA2 GENE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CALCIUM; CALSEQUESTRIN; DOWN-REGULATION; HEART FAILURE; HUMANS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION;

EID: 84864182366     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-057     Document Type: Review

References (96)

1. 2+ leak in heart failure. Circ. Res. 97(12): 1314-1322. doi:10.1161/01.RES.0000194329.41863.89. PMID:16269653.
2. Alpert, N.R., Brosseau, C., Federico, A., Krenz, M., Robbins, J., and Warshaw, D.M. 2002. Molecular mechanics of mouse cardiac myosin isoforms. Am. J. Physiol. Heart Circ. Physiol. 283(4): H1446-H1454. PMID:12234796.
3. Anwar, A., Taimor, G., Korkusuz, H., Schreckenberg, R., Berndt, T., Abdallah, Y., et al. 2005. PKC-independent signal transduction pathways increase SERCA2 expression in adult rat cardiomyocytes. J. Mol. Cell. Cardiol. 39(6): 911-919. doi:10.1016/j.yjmcc. 2005.08.001. PMID:16236312.
4. Arai, M., Otsu, K., MacLennan, D.H., Alpert, N.R., and Periasamy, M. 1991. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ. Res. 69(2): 266-276. PMID:1830516.
5. Arai, M., Tomaru, K., Takizawa, T., Sekiguchi, K., Yokoyama, T., Suzuki, T., and Nagai, R. 1998. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J. Mol. Cell. Cardiol. 30(2): 243-254. doi:10.1006/jmcc.1997.0588. PMID:9515001.
6. Assayag, P., Charlemagne, D., de Leiris, J., Boucher, F., Valere, P.E., Lortet, S., et al. 1997. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension, 29(1): 15-21. PMID:9039074.
7. Azhar, G., Zhang, X., Wang, S., Zhong, Y., Quick, C.M., andWei, J.Y. 2007. Maintaining serum response factor activity in the older heart equal to that of the young adult is associated with better cardiac response to isoproterenol stress. Basic Res. Cardiol. 102 (3): 233-244. doi:10.1007/s00395-006-0634-z. PMID:17122890.
8. 2+ regulates the kinetics of tension development in intact cardiac muscle. Am. J. Physiol. 275(3): H744-H750. PMID:9724275.
9. Bassani, J.W., Qi, M., Samarel, A.M., and Bers, D.M. 1994. Contractile arrest increases sarcoplasmic reticulum calcium uptake and SERCA2 gene expression in cultured neonatal rat heart cells. Circ. Res. 74(5): 991-997. PMID:8156646.
10. Beard, N.A., Laver, D.R., and Dulhunty, A.F. 2004. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog. Biophys. Mol. Biol. 85(1): 33-69. doi:10.1016/j. pbiomolbio.2003.07.001. PMID:15050380.
11. Beard, N.A., Wei, L., and Dulhunty, A.F. 2009. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen. Clin. Exp. Pharmacol. Physiol. 36(3): 340-345. doi:10.1111/j.1440-1681.2008.05094.x. PMID:19278523.
12. Belevych, A.E., Terentyev, D., Terentyeva, R., Nishijima, Y., Sridhar, A., Hamlin, R.L., et al. 2011. The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc. Res. 90(3): 493-502. doi:10.1093/cvr/cvr025. PMID:21273243.
13. Belmont, P.J., Tadimalla, A., Chen, W.J., Martindale, J.J., Thuerauf, D.J., Marcinko, M., et al. 2008. Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene. J. Biol. Chem. 283(20): 14012-14021. doi:10.1074/jbc.M709776200. PMID:18319259.
14. Berger, H.J., Zaret, B.L., Speroff, L., Cohen, L.S., and Wolfson, S. 1976. Regional cardiac prostaglandin release during myocardial ischemia in anesthetized dogs. Circ. Res. 38(6): 566-571. PMID: 1269107.
15. Bers, D.M. 2002. Cardiac excitation-contraction coupling. Nature, 415(6868): 198-205. doi:10.1038/415198a. PMID:11805843.
16. Bers, D.M. 2008. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70(1): 23-49. doi:10.1146/annurev.physiol. 70.113006.100455. PMID:17988210.
17. Bigelow, D.J. 2009. Nitrotyrosine-modified SERCA2: a cellular sensor of reactive nitrogen species. Pflugers Arch. 457(3): 701-710. doi:10.1007/s00424-007-0429-6. PMID:18172601.
18. Blaukat, A., Ivankovic-Dikic, I., Gronroos, E., Dolfi, F., Tokiwa, G., Vuori, K., and Dikic, I. 1999. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J. Biol. Chem. 274(21): 14893-14901. doi:10. 1074/jbc.274.21.14893. PMID:10329689.
19. Boudina, S., and Abel, E.D. 2007. Diabetic cardiomyopathy revisited. Circulation, 115(25): 3213-3223. doi:10.1161/CIRCULATIONAHA.106.679597. PMID:17592090.
20. Brady, M., Koban, M.U., Dellow, K.A., Yacoub, M., Boheler, K.R., and Fuller, S.J. 2003. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc. Res. 60(2): 347-354. doi:10.1016/S0008-6363(03)00529-7. PMID:14613864.
21. Braunwald, E., and Bristow, M.R. 2000. Congestive heart failure: fifty years of progress. Circulation, 102(20 Suppl. 4): IV14-IV23. PMID:11080127.
22. Brini, M., and Carafoli, E. 2009. Calcium pumps in health and disease. Physiol. Rev. 89(4): 1341-1378. doi:10.1152/physrev. 00032.2008. PMID:19789383.
23. Chazov, E.I., Pomoinetsky, V.D., Geling, N.G., Orlova, T.R., Nekrasova, A.A., and Smirnov, V.N. 1979. Heart adaptation to acute pressure overload: an involvement of endogenous prostaglandins. Circ. Res. 45(2): 205-211. PMID:445704.
24. Chopra, N., and Knollmann, B.C. 2009. Cardiac calsequestrin: the new kid on the block in arrhythmias. J. Cardiovasc. Electrophysiol. 20(10): 1179-1185. doi:10.1111/j.1540-8167.2009.01531.x. PMID:19563351.
25. Clark, R.J., McDonough, P.M., Swanson, E., Trost, S.U., Suzuki, M., Fukuda, M., and Dillmann, W.H. 2003. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278(45): 44230-44237. doi:10.1074/jbc.M303810200. PMID:12941958.
26. Dai, D.F., Santana, L.F., Vermulst, M., Tomazela, D.M., Emond, M.J., MacCoss, M.J., et al. 2009. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation, 119(21): 2789-2797. doi:10.1161/CIRCULATIONAHA.108. 822403. PMID:19451351.
27. Dillmann, W. 2010. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail. Rev. 15(2): 125-132. doi:10.1007/s10741-008-9125-7. PMID:19125327.
28. Domenighetti, A.A., Danes, V.R., Curl, C.L., Favaloro, J.M., Proietto, J., and Delbridge, L.M. 2010. Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation. J. Mol. Cell. Cardiol. 48(4): 663-672. doi:10.1016/j.yjmcc.2009.11.017. PMID:19962383.
29. Frank, K.F., Mesnard-Rouiller, L., Chu, G., Young, K.B., Zhao, W., Haghighi, K., et al. 2001. Structure and expression of the mouse cardiac calsequestrin gene. Basic Res. Cardiol. 96(6): 636-644. doi:10.1007/s003950170016. PMID:11770083.
30. 2+ ATPase gene is inhibited by LIF and IL-6. Am. J. Physiol. Endocrinol. Metab. 278(4): E738-E743. PMID: 10751209.
31. Györke, S., Stevens, S.C.W., and Terentyev, D. 2009. Cardiac calsequestrin: quest inside the SR. J. Physiol. 587(13): 3091-3094. doi:10.1113/jphysiol.2009.172049. PMID:19567748.
32. 2+ stores in cardiomyocytes. Cardiovasc. Res. 88(1): 75-82. doi:10.1093/cvr/cvq180. PMID:20525644.
33. Hara, S., Arai, M., Tomaru, K., Doi, H., Koitabashi, N., Iso, T., et al. 2008. Prostaglandin F2a inhibits SERCA2 gene transcription through an induction of Egr-1 in cultured neonatal rat cardiac myocytes. Int. Heart J. 49(3): 329-342. doi:10.1536/ihj.49.329. PMID:18612190.
34. 2+ATPase gene. Demonstration that retinoid X receptor binds 5′ to thyroid hormone receptor in response element 1. J. Biol. Chem. 269(17): 13021-13029. PMID: 8175722.
35. 2+ ATPase (SERCA2) gene expression and calcium reuptake. J. Mol. Cell. Cardiol. 28(12): 2467-2477. doi:10.1006/jmcc.1996.0239. PMID: 9004163.
36. Hayat, S.A., Patel, B., Khattar, R.S., and Malik, R.A. 2004. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin. Sci. 107(6): 539-557. doi:10.1042/CS20040057. PMID:15341511.
37. Heidkamp, M.C., Scully, B.T., Vijayan, K., Engman, S.J., Szotek, E.L., and Samarel, A.M. 2005. PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes. Am. J. Physiol. Cell Physiol. 289(2): C471-C482. doi:10.1152/ajpcell.00130. 2005. PMID:15829561.
38. Hilal-Dandan, R., He, H., Martin, J.L., Brunton, L.L., and Dillmann, W.H. 2009. Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP. Am. J. Physiol. Heart Circ. Physiol. 296(3): H728-H734. doi:10.1152/ajpheart. 00584.2008. PMID:19151257.
39. Hoshijima, M., Knoll, R., Pashmforoush, M., and Chien, K. 2006. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. J. Am. Coll. Cardiol. 48(9 Suppl. 1): A15-A23. doi:10.1016/j.jacc.2006.06.070. PMID:17084280.
40. Jiang, M., Xu, A., and Narayanan, N. 2006. Thyroid hormone downregulates the expression and function of sarcoplasmic reticulum-associated CaM kinase II in the rabbit heart. Am. J. Physiol. Heart. Circ. Physiol. 291: H1384-H1394. doi:10.1152/ajpheart.00875.2005. PMID:16617128.
41. Ju, H., Scammel-La Fleur, T., and Dixon, I.M. 1996. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J. Mol. Cell. Cardiol. 28(5): 1119-1128. doi:10. 1006/jmcc.1996.0103. PMID:8762048.
42. Kahaly, G.J., and Dillmann, W.H. 2005. Thyroid hormone action in the heart. Endocr. Rev. 26(5): 704-728. doi:10.1210/er.2003-0033. PMID:15632316.
43. 2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit. Care Med. 38(1): 217-222. doi:10.1097/CCM.0b013e3181b4a854. PMID:19730253.
44. Kaplan, P., Jurkovicova, D., Babusikova, E., Hudecova, S., Racay, P., Sirova, M., et al. 2007. Effect of aging on the expression of intracellular Ca(2+) transport proteins in a rat heart. Mol. Cell. Biochem. 301(1-2): 219-226. doi:10.1007/s11010-007-9414-9. PMID:17549608.
45. 2+ cycling proteins and the action potential in heart failure by gene transfer. Basic Res. Cardiol. 97(7 Suppl. 1): I136-I145. doi:10. 1007/s003950200042. PMID:12479247.
46. Kasneci, A., Kemeny-Suss, N.M., Komarova, S.V., and Chalifour, L.E. 2009. Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc. Res. 81(4): 695-702. doi:10.1093/cvr/cvn357. PMID:19103607.
47. 2+ ATPase function is increased by aerobic interval training. Eur. J. Cardiovasc. Prev. Rehabil. 15(2): 145-148. doi:10.1097/HJR.0b013e3282efd4e0. PMID:18391639.
48. Knollmann, B.C. 2009. New roles of calsequestrin and triadin in cardiac muscle. J. Physiol. 587(13): 3081-3087. doi:10.1113/jphysiol.2009.172098. PMID:19451205.
49. 2+-ATPase 2 gene transcription through modification of Sp1 binding. Biochem. Biophys. Res. Commun. 328(1): 116-124. doi:10. 1016/j.bbrc.2004.12.139. PMID:15670758.
50. Kurabayashi, M., Jeyaseelan, R., and Kedes, L. 1994. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction. J. Biol. Chem. 269(8): 6031-6039. PMID:8119948.
51. Lai, J., Jin, H., Yang, R., Winer, J., Li, W., Yen, R., et al. 1996. Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am. J. Physiol. 271(6): H2197-H2208. PMID:8997275.
52. Lee, K.W., Maeng, J.S., Choi, J.Y., Lee, Y.R., Hwang, C.Y., Park, S.S., et al. 2012. Role of junctin protein interactions in cellular dynamics of calsequestrin polymer upon calcium perturbation. J. Biol. Chem. 287(3): 1679-1687. doi:10.1074/jbc.M111.254045. PMID:22123818.
53. Lehnart, S.E., Schillinger, W., Pieske, B., Prestle, J., Just, H., and Hasenfuss, G. 1998. Sarcoplasmic reticulum proteins in heart failure. Ann. N. Y. Acad. Sci. 853(1 CARDIAC SARCO): 220-230. doi:10.1111/j.1749-6632.1998.tb08270.x. PMID:10603950.
54. Liu, C.J., Cheng, Y.C., Lee, K.W., Hsu, H.H., Chu, C.H., Tsai, F.J., et al. 2008. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Mol. Cell. Biochem. 313(1-2): 167-178. doi:10.1007/s11010-008-9754-0. PMID:18398669.
55. 2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J. Physiol. 587 (13): 3113-3115. doi:10.1113/jphysiol.2009.172155. PMID: 19567749.
56. Meyer, R., Schreckenberg, R., Kretschmer, F., Bittig, A., Conzelmann, C., Grohe, C., and Schluter, K. 2007. Parathyroid hormone-related protein (PTHrP) signal cascade modulates myocardial dysfunction in the pressure overloaded heart. Eur. J. Heart Fail. 9(12): 1156-1162. doi:10.1016/j.ejheart.2007.10.007. PMID:17997355.
57. Molkentin, J.D. 2004. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc. Res. 63(3): 467-475. doi:10.1016/j.cardiores.2004.01. 021. PMID:15276472.
58. Muller, A., Zuidwijk, M.J., Simonides, W.S., and van Hardeveld, C. 1997. Modulation of SERCA2 expression by thyroid hormone and norepinephrine in cardiocytes: role of contractility. Am. J. Physiol. 272(4): H1876-H1885. PMID:9139974.
59. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 86 (8): 2966-2970. doi:10.1073/pnas.86.8.2966. PMID:2523077.
60. Novák, P., and Soukup, T. 2011. Calsequestrin distribution, structure and function, its role in normal and pathological situations and the effect of thyroid hormones. Physiol. Res. 60(3): 439-452. PMID: 21401301.
61. Palbykin, B., Borg, J., Caldwell, P.T., Rowles, J., Papoutsis, A.J., Romagnolo, D.F., and Selmin, O.I. 2011. Trichloroethylene induces methylation of the Serca2 promoter in H9c2 cells and embryonic heart. Cardiovasc. Toxicol. 11(3): 204-214. doi:10. 1007/s12012-011-9113-3. PMID:21479763.
62. 2+ activation and relaxation in rat and guinea pig skinned trabeculae. Circ. Res. 83 (2): 179-186. PMID:9686757.
63. Pandey, P., Avraham, S., Kumar, S., Nakazawa, A., Place, A., Ghanem, L., et al. 1999. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinasedependent mechanism. J. Biol. Chem. 274(15): 10140-10144. doi:10.1074/jbc.274.15.10140. PMID:10187797.
64. Passier, R., Zeng, H., Frey, N., Naya, F.J., Nicol, R.L., McKinsey, T.A., et al. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105(10): 1395-1406. doi:10.1172/JCI8551. PMID: 10811847.
65. Porter, M.J., Heidkamp, M.C., Scully, B.T., Patel, N., Martin, J.L., and Samarel, A.M. 2003. Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes. Am. J. Physiol. Cell Physiol. 285(1): C39-C47. PMID:12606313.
66. Prasad, A.M., and Inesi, G. 2011. Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 300(1): H173-H180. doi:10.1152/ajpheart. 00841.2010. PMID:21057045.
67. 2+ ATPase (SERCA2) expression in cardiac myocytes. Mol. Cell. Biochem. 361(1-2): 85-96. doi:10.1007/s11010-011-1092-y. PMID:21964539.
68. Reyes-Juárez, J.L., and Zarain-Herzberg, A. 2006. Función del retículo sarcoplásmico y su papel en las enfermedades cardíacas [Function and role of the sarcoplasmic reticulum in heart disease]. Arch. Cardiol. Mex. 76(Suppl. 4): S18-S32. PMID:17469332.
69. Reyes-Juárez, J.L., Juárez-Rubi, R., Rodríguez, G., and Zarain-Herzberg, A. 2007. Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes. J. Biol. Chem. 282(49): 35554-35563. doi:10.1074/jbc.M707788200. PMID: 17938175.
70. 2+-ATPase in the rat heart. J. Biol. Chem. 263(15): 6941-6944. PMID: 2966798.
71. Ronkainen, V.P., Skoumal, R., and Tavi, P. 2011. Hypoxia and HIF-1 suppress SERCA2a expression in embryonic cardiac myocytes through two interdependent hypoxia response elements. J. Mol. Cell. Cardiol. 50(6): 1008-1016. doi:10.1016/j.yjmcc.2011.02. 017. PMID:21382378.
72. Rouf, R., Greytak, S., Wooten, E.C., Wu, J., Boltax, J., Picard, M., et al. 2008. Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription. Circ. Res. 103 (5): 493-501. doi:10.1161/CIRCRESAHA.108.181487. PMID: 18658259.
73. Sato, Y., Ferguson, D.G., Sako, H., Dorn, G.W., II, Kadambi, V.J., Yatani, A., et al. 1998. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J. Biol. Chem. 273 (43): 28470-28477. doi:10.1074/jbc.273.43.28470. PMID: 9774476.
74. 2+ ATPasemRNA in striated muscle. Mol. Cell. Endocrinol. 87(1-3): 87-93. doi:10. 1016/0303-7207(92)90236-Y. PMID:1446789.
75. Sena, S., Hu, P., Zhang, D., Wang, X., Wayment, B., Olsen, C., et al. 2009. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J. Mol. Cell. Cardiol. 46 (6): 910-918. doi:10.1016/j.yjmcc.2009.02.014. PMID:19249310.
76. Soltis, A.R., and Saucerman, J.J. 2010. Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling. Biophys. J. 99(7): 2038-2047. doi:10. 1016/j.bpj.2010.08.016. PMID:20923637.
77. Takizawa, T., Arai, M., Tomaru, K., Koitabashi, N., Baker, D.L., Periasamy, M., and Kurabayashi, M. 2003. Transcription factor Sp1 regulates SERCA2 gene expression in pressure-overloaded hearts: a study using in vivo direct gene transfer into living myocardium. J. Mol. Cell. Cardiol. 35(7): 777-783. doi:10.1016/S0022-2828(03)00122-6. PMID:12818568.
78. 2+ uptake but decreases myocyte shortening. Circulation, 110 (23): 3553-3559. doi:10.1161/01.CIR.0000145161.48545.B3. PMID:15505097.
79. Thuerauf, D.J., Hoover, H., Meller, J., Hernandez, J., Su, L., Andrews, C., et al. 2001. Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J. Biol. Chem. 276(51): 48309-48317. PMID:11595740.
80. Uehara, Y., Azuma, Y., Minai, K., Yoshida, H., Yoshimura, M., and Shimizu, M. 2012. Endothelin-1 prolongs intracellular calcium transient decay in neonatal rat cardiac myocytes. Heart Vessels, 27 (1): 98-105. doi:10.1007/s00380-011-0133-5. PMID:21445599.
81. van Oort, R.J., McCauley, M.D., Dixit, S.S., Pereira, L., Yang, Y., Respress, J.L., et al. 2010. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes lifethreatening ventricular arrhythmias in mice with heart failure. Circulation, 122(25): 2669-2679. doi:10.1161/CIRCULATIONAHA.110.982298. PMID:21098440.
82. Vandecaetsbeek, I., Raeymaekers, L., Wuytack, F., and Vangheluwe, P. 2009. Factors controlling the activity of the SERCA2a pump in the normal and failing heart. Biofactors, 35(6): 484-499. doi:10. 1002/biof.63. PMID:19904717.
83. 2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium, 38(3-4): 291-302. doi:10.1016/j.ceca.2005.06.033. PMID: 16105684.
84. Vannier, C., Chevassus, H., and Vassort, G. 1996. Ca-dependence of isometric force kinetics in single skinned ventricular cardiomyocytes from rats. Cardiovasc. Res. 32(3): 580-586. PMID:8881518.
85. Vlasblom, R., Muller, A., Musters, R.J., Zuidwijk, M.J., Van Hardeveld, C., Paulus, W.J., and Simonides, W.S. 2004. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc. Res. 63(3): 537-544. doi:10.1016/j.cardiores. 2004.04.005. PMID:15276479.
86. Watanabe, A., Arai, M., Koitabashi, N., Niwano, K., Ohyama, Y., Yamada, Y., et al. 2011. Mitochondrial transcription factors TFAM and TFB2M regulate SERCA2 gene transcription. Cardiovasc. Res. 90(1): 57-67. doi:10.1093/cvr/cvq374. PMID:21113058.
87. Wescombe, L., Lahooti, H., Gopinath, B., and Wall, J.R. 2010. The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy-support for a role of autoimmunity against calsequestrin as the triggering event. Clin. Endocrinol. (Oxf.), 73(4): 522-528. PMID:20039900.
88. 2+ adenosine triphosphatase gene. Endocrinology, 138(1): 114-120. doi:10.1210/en.138.1.114. PMID: 8977393.
89. 2+ ATPase. Crit. Care Med. 39(5): 984-992. doi:10.1097/CCM. 0b013e31820a91b9. PMID:21263314.
90. Yano, K., and Zarain-Herzberg, A. 1994. Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol. Cell. Biochem. 135(1): 61-70. doi:10.1007/BF00925961. PMID: 7816057.
91. Yokoe, S., Asahi, M., Takeda, T., Otsu, K., Taniguchi, N., Miyoshi, E., and Suzuki, K. 2010. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Glycobiology, 20(10): 1217-1226. doi:10.1093/glycob/cwq071. PMID:20484118.
92. Yoshida, H. 2007. ER stress and diseases. FEBS J. 274(3): 630-658. doi:10.1111/j.1742-4658.2007.05639.x. PMID:17288551.
93. 2+-ATPase expression in the hypertrophic and failing heart. Can. J. Physiol. Pharmacol. 84(5): 509-521. doi:10.1139/y06-023. PMID:16902596.
94. 2+-ATPase-2 gene: structure and transcriptional regulation of the human gene. ScientificWorldJournal, 2: 1469-1483. doi:10.1100/tsw.2002.228. PMID:12805933.
95. Zarain-Herzberg, A., Marques, J., Sukovich, D., and Periasamy, M. 1994. Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. J. Biol. Chem. 269(2): 1460-1467. PMID:8166809.
96. 2+-ATPase promoter in myocardial ischemia-preconditioning. Mol. Cell. Biochem. 333(1-2): 311-321. doi:10.1007/s11010-009-0232-0. PMID:19714449.